Related Experiment Video
Updated: Mar 2, 2026
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingosine metabolism as a therapeutic target in cutaneous melanoma
1College of Medicine, Medical University of South Carolina, Charleston, SC.
Abstract:
Melanoma is by far the most aggressive type of skin cancer with a poor prognosis in its advanced stages. Understanding the mechanisms involved in melanoma pathogenesis, response, and resistance to treatment has gained a lot of attention worldwide. Recently, the role of sphingolipid metabolism has been studied in cutaneous melanoma. Sphingolipids are bioactive lipid effector molecules involved in the regulation of various cellular signaling pathways such as inflammation, cancer cell proliferation, death, senescence, and metastasis. Recent studies suggest that sphingolipid metabolism impacts melanoma pathogenesis and is a potential therapeutic target. This review focuses on defining the role of sphingolipid metabolism in melanoma carcinogenesis, discussing sphingolipid-based therapeutic approaches, and highlighting the areas that require more extensive research.
Insights
Sphingolipid metabolism significantly influences melanoma development and progression. Targeting these pathways offers a promising therapeutic strategy for advanced skin cancer.
Area of Science:
- Oncology
- Biochemistry
- Dermatology
Background:
- Melanoma is an aggressive skin cancer with poor outcomes in advanced stages.
- Understanding melanoma's molecular mechanisms, including treatment resistance, is crucial.
- Sphingolipid metabolism is increasingly recognized for its role in various cellular processes relevant to cancer.
Purpose of the Study:
- To review the role of sphingolipid metabolism in melanoma carcinogenesis.
- To discuss sphingolipid-based therapeutic strategies for melanoma.
- To identify research gaps in sphingolipid metabolism and melanoma.
Main Methods:
- Literature review of studies on sphingolipid metabolism in cutaneous melanoma.
- Analysis of sphingolipid's involvement in melanoma pathogenesis.
- Evaluation of sphingolipid-based therapeutic approaches.
Main Results:
- Sphingolipids are bioactive lipids regulating key cellular pathways like proliferation, death, and metastasis.
- Alterations in sphingolipid metabolism are implicated in melanoma development.
- Sphingolipid metabolism represents a potential therapeutic target for melanoma.
Conclusions:
- Sphingolipid metabolism plays a critical role in melanoma.
- Targeting sphingolipid pathways may offer novel therapeutic avenues.
- Further research is needed to fully elucidate these mechanisms and optimize treatments.
